{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:41:56Z","timestamp":1761597716922},"reference-count":23,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3892\/or.2016.4821","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T20:08:39Z","timestamp":1463688519000},"page":"299-305","source":"Crossref","is-referenced-by-count":15,"title":["Effects of TMEM9 gene on cell progression in hepatocellular carcinoma by RNA interference"],"prefix":"10.3892","volume":"36","author":[{"given":"YI","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAN","family":"RAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAN","family":"XIONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZI-BIAO","family":"ZHONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHENG-HUA","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAO-LI","family":"FAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QI-FA","family":"YE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,5,19]]},"reference":[{"key":"key20180107221823_b1-or-36-01-0299","doi-asserted-by":"crossref","DOI":"10.1016\/B978-012373960-5.00335-X","volume-title":"The Global Burden of Disease: 2004 Update","author":"Mathers","year":"2008"},{"key":"key20180107221823_b2-or-36-01-0299","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"key20180107221823_b3-or-36-01-0299","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: Worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"key20180107221823_b4-or-36-01-0299","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2006-960171","article-title":"Genomics and signaling pathways in hepatocellular carcinoma","volume":"27","author":"Villanueva","year":"2007","journal-title":"Semin Liver Dis"},{"key":"key20180107221823_b5-or-36-01-0299","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jhep.2008.07.023","article-title":"Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B","volume":"50","author":"Yuen","year":"2009","journal-title":"J Hepatol"},{"key":"key20180107221823_b6-or-36-01-0299","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2009.27.4456","article-title":"Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection","volume":"28","author":"Yang","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107221823_b7-or-36-01-0299","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","article-title":"Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease","volume":"136","author":"Lok","year":"2009","journal-title":"Gastroenterology"},{"key":"key20180107221823_b8-or-36-01-0299","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening","volume":"48","author":"Yeoman","year":"2008","journal-title":"Hepatology"},{"key":"key20180107221823_b9-or-36-01-0299","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S2095-4964(15)60171-6","article-title":"Chinese medicines for prevention and treatment of human hepatocellular carcinoma: Current progress on pharmacological actions and mechanisms","volume":"13","author":"Wang","year":"2015","journal-title":"J Integr Med"},{"key":"key20180107221823_b10-or-36-01-0299","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1365-2036.2006.02932.x","article-title":"Systematic review: Evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials","volume":"23","author":"Lopez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180107221823_b11-or-36-01-0299","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/CCO.0b013e328302c9e9","article-title":"Linking molecular classification of hepatocellular carcinoma and personalized medicine: Preliminary steps","volume":"20","author":"Villanueva","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"key20180107221823_b12-or-36-01-0299","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2011.02.008","article-title":"CD151 amplifies signaling by integrin \u03b16\u03b21 to PI3K and induces the epithelial-mesenchymal transition in HCC Cells","volume":"140","author":"Ke","year":"2011","journal-title":"Gastroenterology"},{"key":"key20180107221823_b13-or-36-01-0299","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0006-291X(02)02228-3","article-title":"Characterization of the novel human transmembrane protein 9 (TMEM9) that localizes to lysosomes and late endosomes","volume":"297","author":"Kveine","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107221823_b14-or-36-01-0299","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107221823_b15-or-36-01-0299","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cncr.26251","article-title":"FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo","volume":"118","author":"Fang","year":"2012","journal-title":"Cancer"},{"key":"key20180107221823_b16-or-36-01-0299","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3736\/jintegrmed2013021","article-title":"Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial","volume":"11","author":"Zhai","year":"2013","journal-title":"J Integr Med"},{"key":"key20180107221823_b17-or-36-01-0299","article-title":"The Cell Cycle: Principles of Control","author":"Morgan","year":"2007","journal-title":"New Science Press"},{"key":"key20180107221823_b18-or-36-01-0299","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2013.06.019","article-title":"Eukaryotic translation initiation factors in cancer development and progression","volume":"340","author":"Spilka","year":"2013","journal-title":"Cancer Lett"},{"key":"key20180107221823_b19-or-36-01-0299","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/jhep.2003.50457","article-title":"PTK2 and EIF3S3 genes may be amplification targets at 8q23\u2013q24 and are associated with large hepatocellular carcinomas","volume":"38","author":"Okamoto","year":"2003","journal-title":"Hepatology"},{"key":"key20180107221823_b20-or-36-01-0299","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/JTO.0b013e31819a5767","article-title":"MYC and EIF3H coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib","volume":"4","author":"Cappuzzo","year":"2009","journal-title":"J Thorac Oncol"},{"key":"key20180107221823_b21-or-36-01-0299","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/j.1460-2075.1995.tb07153.x","article-title":"Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus","volume":"14","author":"Jackman","year":"1995","journal-title":"EMBO J"},{"key":"key20180107221823_b22-or-36-01-0299","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood.V95.8.2645","article-title":"Abundance of cyclin B1 regulates \u03b3-radiation-induced apoptosis","volume":"95","author":"Porter","year":"2000","journal-title":"Blood"},{"key":"key20180107221823_b23-or-36-01-0299","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00424-007-0313-4","article-title":"S100A10\/p11: Family, friends and functions","volume":"455","author":"Rescher","year":"2008","journal-title":"Pflugers Arch"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4821\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T04:48:47Z","timestamp":1600577327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,19]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,19]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.3892\/or.2016.4821"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4821","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,19]]}}}